Three-dimensional analysis of synaptic organization in the hippocampal CA1 field in Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Alzheimer’s disease is the most common form of dementia, characterized by a persistent and progressive impairment of cognitive functions. Alzheimer’s disease is typically associated with extracellular deposits of amyloid-β peptide and accumulation of abnormally phosphorylated tau protein inside neurons (amyloid-β and neurofibrillary pathologies). It has been proposed that these pathologies cause neuronal degeneration and synaptic alterations, which are thought to constitute the major neurobiological basis of cognitive dysfunction in Alzheimer’s disease. The hippocampal formation is especially vulnerable in the early stages of Alzheimer’s disease. However, the vast majority of electron microscopy studies have been performed in animal models. In the present study, we performed an extensive 3D study of the neuropil to investigate the synaptic organization in the stratum pyramidale and radiatum in the CA1 field of Alzheimer’s disease cases with different stages of the disease, using focused ion beam/scanning electron microscopy (FIB/SEM). In cases with early stages of Alzheimer’s disease, the synapse morphology looks normal and we observed no significant differences between control and Alzheimer’s disease cases regarding the synaptic density, the ratio of excitatory and inhibitory synapses, or the spatial distribution of synapses. However, differences in the distribution of postsynaptic targets and synaptic shapes were found. Furthermore, a lower proportion of larger excitatory synapses in both strata were found in Alzheimer’s disease cases. Individuals in late stages of the disease suffered the most severe synaptic alterations, including a decrease in synaptic density and morphological alterations of the remaining synapses. Since Alzheimer’s disease cases show cortical atrophy, our data indicate a reduction in the total number (but not the density) of synapses at early stages of the disease, with this reduction being much more accentuated in subjects with late stages of Alzheimer’s disease. The observed synaptic alterations may represent a structural basis for the progressive learning and memory dysfunctions seen in Alzheimer’s disease cases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420 · cited 1×
“Synaptic failure has been postulated as the main cause of Alzheimer’s disease pathology (Selkoe, 2002).”
BackgroundNeuropathological alterations in Alzheimer disease
Serrano-Pozo, A., Frosch, M. P., Masliah, E., & Hyman, B. T. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006189 · Cited by 3,345 · cited 1×
“Medial temporal lobe structures, consisting of the hippocampal formation and adjacent cortices, are essential for the proper functioning of spatial and declarative memory systems (Dickerson and Eichenbaum, 2010; Serrano-Pozo et al., 2011) and are the first areas affected in the progression of the disease (Braak and Br…”
BackgroundThe Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280 · cited 1×
“…synaptic and neurological dysfunction may come as a result of vascular disruption, which could lead to an entry of neurotoxic molecules in the brain and to improper energy metabolite and nutrient delivery, among other factors (Zlokovic, 2008, 2011; Sagare et al., 2012; Nelson et al., 2016).”
BackgroundNeurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders
Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376
Nelson, P. T., Alafuzoff, I., Bigio, E. H., Bouras, C., Braak, H., Cairns, N. J., Castellani, R. J., Crain, B. J., Davies, P., Tredici, K. D., et al. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31825018f7 · Cited by 2,050 · cited 1×
“the association with the degree of amyloid and tau pathology remains controversial (DeKosky and Scheff, 1990; Terry et al., 1991; Sze et al., 1997; Scheff and Price, 2003; Nelson et al., 2012; Spires-Jones and Hyman, 2014).”
BackgroundSüdhof, T. C. (2012) · Neuron · doi:10.1016/j.neuron.2012.06.012 · Cited by 1,251 · cited 1×
“The shape and size of the synaptic junctions are strongly correlated with release probability, synaptic strength, efficacy and plasticity (Ganeshina et al., 2004a, b; Tarusawa et al., 2009; Holderith et al., 2012; Südhof, 2012; Biederer et al., 2017; Wegner et al., 2018).”
BackgroundThe Intersection of Amyloid Beta and Tau at Synapses in Alzheimer’s Disease
Spires-Jones, T. L., & Hyman, B. T. (2014) · Neuron · doi:10.1016/j.neuron.2014.05.004 · Cited by 1,201
Lacor, P. N., Buniel, M. C., Furlow, P. W., Sanz Clemente, A., Velasco, P. T., Wood, M., Viola, K. L., & Klein, W. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3501-06.2007 · Cited by 1,188 · cited 1×
“…generating toxic effects under pathological conditions, leading to synaptic loss and neurotransmitter release dysfunction (Gylys et al., 2004; Lacor et al., 2007; Merino-Serrais et al., 2011, 2013; Wilcox et al., 2011; Spires-Jones and Hyman, 2014; Dorostkar et al., 2015; Henstridge et al.,…”
BackgroundHarris, K., & Stevens, J. (1989) · The Journal of Neuroscience · doi:10.1523/jneurosci.09-08-02982.1989 · Cited by 1,073
Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment
Scheff, S. W., Price, D. A., Schmitt, F. A., & Mufson, E. J. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.012 · Cited by 1,017
Quantitative ultrastructural analysis of hippocampal excitatory synapses
Schikorski, T., & Stevens, C. F. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-15-05858.1997 · Cited by 997
TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease
Amador‐Ortiz, C., Lin, W., Ahmed, Z., Personett, D., Davies, P., Duara, R., Graff‐Radford, N. R., Hutton, M. L., & Dickson, D. W. (2007) · Annals of Neurology · doi:10.1002/ana.21154 · Cited by 916 · cited 1×
“7B) that is often associated with Alzheimer’s disease (Dickson et al., 1994; Velez-Pardo et al., 2004; Attems and Jellinger, 2006; Amador-Ortiz et al., 2007).”
BackgroundNeuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease
Price, J. L., McKeel, D. W., Buckles, V. D., Roe, C. M., Xiong, C., Grundman, M., Hansen, L. A., Petersen, R. C., Parisi, J. E., Dickson, D. W., et al. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.04.002 · Cited by 661 · cited 1×
“While abnormal phosphorylated tau protein forming neurofibrillary tangles (NFTs) and aberrant amyloid-b deposition have been described as the main neuropathological hallmarks of Alzheimer’s disease, they have also been found in the aged brain with no apparent cognitive impairment (Mufson et al., 1999; Price et al., 20…”
BackgroundDavies, C. A., Mann, D. M. A., Sumpter, P. Q., & Yates, P. O. (1987) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(87)90057-8 · Cited by 628
Vascular contributions to cognitive impairment and dementia including Alzheimer's disease
Snyder, H. M., Corriveau, R. A., Craft, S., Faber, J. E., Greenberg, S. M., Knopman, D., Lamb, B. T., Montine, T. J., Nedergaard, M., Schaffer, C. B., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.10.008 · Cited by 603 · cited 1×
“Mounting evidence supports cerebrovascular dysfunction contributing to dementia and Alzheimer’s disease (Zlokovic, 2011; Montine et al., 2014; Montagne et al., 2015; Snyder et al., 2015; Sweeney et al., 2015; Nelson et al., 2016).”
BackgroundSpine growth precedes synapse formation in the adult neocortex in vivo
Knott, G. W., Holtmaat, A., Wilbrecht, L., Welker, E., & Svoboda, K. (2006) · Nature Neuroscience · doi:10.1038/nn1747 · Cited by 563
SZE, C.-I., TRONCOSO, J. C., KAWAS, C., MOUTION, P., PRICE, D. L., & MARTIN, L. J. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199708000-00011 · Cited by 562 · cited 2×
“Synapse loss correlates with cognitive performance in Alzheimer’s disease (DeKosky and Scheff, 1990; Terry et al., 1991; Sze et al., 1997; Scheff and Price, 2003) and has been inferred mainly from the study of synaptic markers at the light microscope level (Masliah et al.”
BackgroundNeurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease
Nelson, A. R., Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.12.016 · Cited by 559 · cited 2×
“According to this hypothesis, synaptic and neurological dysfunction may come as a result of vascular disruption, which could lead to an entry of neurotoxic molecules in the brain and to improper energy metabolite and nutrient delivery, among other factors (Zlokovic, 2008, 2011; Sagare et al., 2012; Nelson et al., 2016…”
BackgroundUltrastructure of dendritic spines: correlation between synaptic and spine morphologies
Arellano, J. I. (2007) · Frontiers in Neuroscience · doi:10.3389/neuro.01.1.1.010.2007 · Cited by 529
Synaptic degeneration in Alzheimer's disease
Arendt, T. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0536-x · Cited by 517
Entorhinal cortex pathology in Alzheimer's disease
van Hoesen, G. W., Hyman, B. T., & Damasio, A. R. (1991) · Hippocampus · doi:10.1002/hipo.450010102 · Cited by 475
Memory‐related neural systems in Alzheimer's disease: An anatomic study
Hyman, B. T., Hoesen, G. W. V., & Damasio, A. R. (1990) · Neurology · doi:10.1212/wnl.40.11.1721 · Cited by 449
Quantitative assessment of cortical synaptic density in Alzheimer's disease
Scheff, S. W., DeKosky, S. T., & Price, D. A. (1990) · Neurobiology of Aging · doi:10.1016/0197-4580(90)90059-9 · Cited by 446 · cited 2×
“Synapse loss correlates with cognitive performance in Alzheimer’s disease (DeKosky and Scheff, 1990; Terry et al., 1991; Sze et al., 1997; Scheff and Price, 2003) and has been inferred mainly from the study of synaptic markers at the light microscope level (Masliah et al., 1990; Honer et al., 1992;…”
BackgroundTau association with synaptic vesicles causes presynaptic dysfunction
Zhou, L., McInnes, J., Wierda, K., Holt, M., Herrmann, A. G., Jackson, R. J., Wang, Y.-C., Swerts, J., Beyens, J., Miskiewicz, K., et al. (2017) · Nature Communications · doi:10.1038/ncomms15295 · Cited by 434 · cited 1×
“There are numerous studies providing a wealth of evidence for amyloid-b peptides and abnormally phosphorylated tau proteins generating toxic effects under pathological conditions, leading to synaptic loss and neurotransmitter release dysfunction (Gylys et al., 2004; Lacor et al., 2007; Merino-Serrais et al., 2011, 201…”
BackgroundSynaptic Impairment in Alzheimer’s Disease: A Dysregulated Symphony
Forner, S., Baglietto-Vargas, D., Martini, A. C., Trujillo-Estrada, L., & LaFerla, F. M. (2017) · Trends in Neurosciences · doi:10.1016/j.tins.2017.04.002 · Cited by 430
Release probability of hippocampal glutamatergic terminals scales with the size of the active zone
Holderith, N., Lorincz, A., Katona, G., Rózsa, B., Kulik, A., Watanabe, M., & Nusser, Z. (2012) · Nature Neuroscience · doi:10.1038/nn.3137 · Cited by 405
Structural Correlates of Cognition in Dementia: Quantification and Assessment of Synapse Change
DeKosky, S. T., Scheff, S. W., & Styren, S. D. (1996) · Neurodegeneration · doi:10.1006/neur.1996.0056 · Cited by 405
THE FINE STRUCTURE OF NEUROFIBRILLARY TANGLES IN ALZHEIMERʼS DISEASE
Terry, R. D. (1963) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-196310000-00005 · Cited by 403 · cited 5×
“Similarly, the presence of tau aggregates forming intraneuronal NFTs was associated with a progressive decrease in the proportion of larger spines, depending on the degree of tangle development (Merino-Serrais et al., 2013).”
BackgroundInfluentialSynaptic pathology in Alzheimer's disease: a review of ultrastructural studies
Scheff, S. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.08.002 · Cited by 391
Clinical and pathological correlates of apolipoprotein E ε4 in Alzheimer's disease
Gomez‐Isla, T., West, H. L., Rebeck, G. W., Harr, S. D., Growdon, J. H., Locascio, J. J., Perls, T. T., Lipsitz, L. A., & Hyman, B. T. (1996) · Annals of Neurology · doi:10.1002/ana.410390110 · Cited by 378 · cited 1×
“This is in line with previous studies reporting the loss of neurons in Alzheimer’s disease in several brain regions, including the hippocampus (Van Hoesen et al., 1991; Scott et al., 1992; Gomez-Isla et al., 1996; West et al., 2004; Simi c et al., 2017).”
ResultTranscellular Nanoalignment of Synaptic Function
Biederer, T., Kaeser, P. S., & Blanpied, T. A. (2017) · Neuron · doi:10.1016/j.neuron.2017.10.006 · Cited by 352
Hippocampal neurons in pre-clinical Alzheimer's disease.
West, M. J., Kawas, C. H., Stewart, W. F., Rudow, G. L., & Troncoso, J. C. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.12.005 · Cited by 317 · cited 2×
“neuronal loss and dendritic alterations in Alzheimer’s disease patients (Hyman et al., 1990; West et al., 2004; AndradeMoraes et al., 2013; Llorens-Martı́n et al., 2014; Furcila et al., 2019).”
BackgroundResultWeller, R. O., Boche, D., & Nicoll, J. A. R. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0498-z · Cited by 297 · cited 1×
“Microvascular changes in the brain have been documented both in normal ageing and in Alzheimer’s disease (Weller et al., 2009).”
BackgroundIntegration of biochemical signalling in spines
Kennedy, M. B., Beale, H. C., Carlisle, H. J., & Washburn, L. R. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1685 · Cited by 286 · cited 1×
“For instance, a reduction in the transcription of genes related to synaptic efficacy (Murphy, 2003; Yao et al., 2003; Kennedy et al., 2005; Marsh and Alifragis, 2018) has been reported in association with Alzheimer’s disease pathology.”
BackgroundAlzheimer’s disease-related alterations in synaptic density: neocortex and hippocampus.
Scheff, S. W., & Price, D. A. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-9s312 · Cited by 284
Chronic Psychological Distress and Risk of Alzheimer’s Disease in Old Age
Wilson, R. S., Arnold, S. E., Schneider, J. A., Kelly, J. F., Tang, Y., & Bennett, D. A. (2006) · Neuroepidemiology · doi:10.1159/000095761 · Cited by 266 · cited 1×
“Episodic memory loss and disorientation are among the first symptoms reported by Alzheimer’s disease patients (Wilson et al., 2006).”
BackgroundSynaptic dysfunction in Alzheimer's disease: Mechanisms and therapeutic strategies
Chen, Y., Fu, A. K. Y., & Ip, N. Y. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.11.006 · Cited by 258
Synaptic Changes in Alzheimer's Disease
Gylys, K. H., Fein, J. A., Yang, F., Wiley, D. J., Miller, C. A., & Cole, G. M. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63436-0 · Cited by 253
Neuropathologic Alterations in Mild Cognitive Impairment: A Review
Markesbery, W. R. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1220 · Cited by 236 · cited 1×
“…tangles (NFTs) and aberrant amyloid-b deposition have been described as the main neuropathological hallmarks of Alzheimer’s disease, they have also been found in the aged brain with no apparent cognitive impairment (Mufson et al., 1999; Price et al., 2009; Markesbery, 2010; Ferrer, 2012).”
BackgroundAnalyzing dendritic spine pathology in Alzheimer’s disease: Problems and opportunities
Dorostkar, M. M., Zou, C., Blazquez-Llorca, L., & Herms, J. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1449-5 · Cited by 235 · cited 4×
“…leading to synaptic loss and neurotransmitter release dysfunction (Gylys et al., 2004; Lacor et al., 2007; Merino-Serrais et al., 2011, 2013; Wilcox et al., 2011; Spires-Jones and Hyman, 2014; Dorostkar et al., 2015; Henstridge et al., 2016; Rajmohan and Reddy, 2017; Zhou et al., 2017).”
BackgroundInfluentialQuantitative fine-structural analysis of olfactory cortical synapses
Schikorski, T., & Stevens, C. F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.4107 · Cited by 204
Estimation of the number of synapses in the cerebral cortex: methodological considerations
DeFelipe, J. (1999) · Cerebral Cortex · doi:10.1093/cercor/9.7.722 · Cited by 193 · cited 1×
“The regions selected for the acquisition of the stacks of FIB/SEM images were from the neuropil, where more synaptic contacts take place, i.e. avoiding the neuronal and glial somata, blood vessels, large dendrites and myelinated axons (DeFelipe et al., 1999) (Fig.”
BackgroundSelf-citationMerchan-Pérez, A. (2009) · Frontiers in Neuroanatomy · doi:10.3389/neuro.05.018.2009 · Cited by 191 · cited 22×
“FIB/SEM technology allows the examination of a very high number of synapses in serial sections (Merchán-Pérez et al., 2009).”
BackgroundMethodResultInfluentialRegional synaptic pathology in Alzheimer's disease
Honer, W. G., Dickson, D. W., Gleeson, J., & Davies, P. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90111-a · Cited by 179
Severely dystrophic axons at amyloid plaques remain continuous and connected to viable cell bodies
Adalbert, R., Nogradi, A., Babetto, E., Janeckova, L., Walker, S. A., Kerschensteiner, M., Misgeld, T., & Coleman, M. P. (2009) · Brain · doi:10.1093/brain/awn312 · Cited by 177 · cited 1×
“, 2013), while it has been proposed that plaques trigger local alterations in the neuronal structures located in their proximity (Adalbert et al., 2009; Garcı́a-Marin et al., 2009; Blazquez-Llorca et al., 2013; Dorostkar et al., 2015).”
BackgroundFerrer, I. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.03.005 · Cited by 174 · cited 2×
“While abnormal phosphorylated tau protein forming neurofibrillary tangles (NFTs) and aberrant amyloid-b deposition have been described as the main neuropathological hallmarks of Alzheimer’s disease, they have also been found in the aged brain with no apparent cognitive impairment (Mufson et al., 1999; Price et al., 20…”
BackgroundDiminished perisomatic GABAergic terminals on cortical neurons adjacent to amyloid plaques
Garcia-Marin, V. (2009) · Frontiers in Neuroanatomy · doi:10.3389/neuro.05.028.2009 · Cited by 136
Merino-Serrais, P., Benavides-Piccione, R., Blazquez-Llorca, L., Kastanauskaite, A., Rábano, A., Avila, J., & DeFelipe, J. (2013) · Brain · doi:10.1093/brain/awt088 · Cited by 134 · cited 4×
“By contrast, the presence of tau aggregates forming intraneuronal NFTs (immunoreactive for PHF-Tau-AT8 and PHF-Tau-PHF1) is associated with a progressive loss of dendritic spines and changes in their morphology, depending on the degree of tangle development (Merino-Serrais et al., 2013).”
BackgroundInfluentialSelf-citationWidespread Changes in Dendritic Spines in a Model of Alzheimer's Disease
Knafo, S., Alonso-Nanclares, L., Gonzalez-Soriano, J., Merino-Serrais, P., Fernaud-Espinosa, I., Ferrer, I., & DeFelipe, J. (2009) · Cerebral Cortex · doi:10.1093/cercor/bhn111 · Cited by 132
Self-citationCerebrospinal Fluid Biomarkers of Neurovascular Dysfunction in Mild Dementia and Alzheimer'S Disease
Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.76 · Cited by 122 · cited 1×
“Mounting evidence supports cerebrovascular dysfunction contributing to dementia and Alzheimer’s disease (Zlokovic, 2011; Montine et al., 2014; Montagne et al., 2015; Snyder et al., 2015; Sweeney et al., 2015; Nelson et al., 2016).”
BackgroundThree-dimensional analysis of synapses in the transentorhinal cortex of Alzheimer’s disease patients
Domínguez-Álvaro, M., Montero-Crespo, M., Blazquez-Llorca, L., Insausti, R., DeFelipe, J., & Alonso-Nanclares, L. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0520-6 · Cited by 79 · cited 6×
“In this regard, a previous study using SAS measurements failed to report any synaptic size differences in the human transentorhinal cortex of Alzheimer’s disease cases (Domı́nguez-Álvaro et al., 2018).”
BackgroundMethodResultInfluentialSelf-citationCambon, K., Davies, H. A., & Stewart, M. G. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00065-8 · Cited by 63 · cited 1×
“In contrast with our results, previous studies have reported an increment in synaptic apposition length in different brain regions in animal models of Alzheimer’s disease (Hillman and Chen, 1984; Cambon et al., 2000) and humans (Davies et al.”
ResultThree-dimensional synaptic organization of the human hippocampal CA1 field
Montero-Crespo, M., Dominguez-Alvaro, M., Rondon-Carrillo, P., Alonso-Nanclares, L., DeFelipe, J., & Blazquez-Llorca, L. (2020) · eLife · doi:10.7554/elife.57013 · Cited by 60 · cited 10×
“Figs 1A–E, K–O, 2 and 3A–D) that were similar to those in the control cases (Supplementary Fig. 1F–J and P–T; Montero-Crespo et al., 2020).”
BackgroundMethodResultInfluentialSelf-citationSynaptic Changes in the Dentate Gyrus of APP/PS1 Transgenic Mice Revealed by Electron Microscopy
Alonso-Nanclares, L., Merino-Serrais, P., Gonzalez, S., & DeFelipe, J. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31828d41ec · Cited by 45 · cited 1×
“, 2020) and Alzheimer’s disease cases followed a random spatial distribution, as has been observed previously in the somatosensory cortex of normal rats; the molecular layer of dentate gyrus of APP/PS1 transgenic mice; and the frontal cortex of Alzheimer’s disease and the transentorhinal cortex of both control and Alz…”
BackgroundSelf-citationBraak, H., & Del Tredici, K. (2020) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlz123 · Cited by 40
Cited by
Meftah, S., & Gan, J. (2023) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2023.1129036 · Cited by 205
Neuroimaging of mouse models of Alzheimer’s disease
Jullienne, A., Trinh, M. V., & Obenaus, A. (2022) · Biomedicines · doi:10.3390/biomedicines10020305 · Cited by 32
3D synaptic organization of layer III of the human anterior cingulate and temporopolar cortex
Cano-Astorga, N., Plaza-Alonso, S., DeFelipe, J., & Alonso-Nanclares, L. (2023) · Cerebral Cortex · doi:10.1093/cercor/bhad232 · Cited by 26
Self-citationUnambiguous identification of asymmetric and symmetric synapses using volume electron microscopy
Cano-Astorga, N., Plaza-Alonso, S., Turegano-Lopez, M., Rodrigo-Rodríguez, J., Merchan-Perez, A., & DeFelipe, J. (2024) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2024.1348032 · Cited by 20
Self-citationDíaz González, M., Buberman, A., Morales, M., Ferrer, I., & Knafo, S. (2021) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2021.683290 · Cited by 12
Metadata
- Authors
- Montero-Crespo, M., Domínguez-Álvaro, M., Alonso-Nanclares, L., DeFelipe, J., & Blazquez-Llorca, L.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-01-19
- Volume
- 144
- Issue
- 2
- Pages
- 553-573
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W3110888695
- Cited by
- 89
- References
- 58
- FWCI
- 6.54
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.